ARROWHEAD PHARMACEUTICALS, INC.
ARROWHEAD PHARMACEUTICALS, INC.
PASADENA, CA
Loading...
Price History
Market Data
| Market Cap | 10.07B |
| P/E Ratio | 48.04 |
| P/B Ratio | 17.72 |
| EPS | 1.53 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 3.38 |
| Currency | USD |
Key Financial Metrics
1.09B
Revenue
202.26M
Net Income
1.53
EPS (Diluted)
469.19M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
27.6%
Net Profit Margin
18.5%
EBITDA
341.81M
Returns & Efficiency
Return on Assets (ROA)
12.6%
Return on Equity (ROE)
35.6%
Dividend Yield
-
EPS
1.53
Financial Health
Total Assets
1.60B
Total Debt
-
Debt to Equity
-
Current Ratio
3.38
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Engineering, Accounting & Management Services |
| HQ | PASADENA, CA |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$10.07B
P/E Ratio (TTM)48.0
Price to Book17.72
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin27.6%
Net Margin18.5%
ROE35.6%
ROA12.6%
Leverage & Liquidity
Debt to Equity-
Current Ratio3.38
Total Debt-
Total Assets$1.60B
Stockholders' Equity$568.42M
Income Statement (FY 2025)
Revenue$1.09B
Gross Profit-
Operating Income$300.57M
Net Income$202.26M
EPS (Diluted)$1.53
Cash Flow (FY 2025)
Free Cash Flow$469.19M
Cash & Equivalents-
Revenue Growth31.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 177 E COLORADO BLVD SUITE 700 PASADENA, CA 91105 |
| Phone | 626-696-4702 |
| Incorporated | DE, US |
| EIN | 460408024 |
| Fiscal Year End | 0930 |
| Shares Outstanding | 137.04M |
| Stockholders' Equity | $568.42M |
Recent Filings
View All
S-8
Employee Plan Registration
Registration for employee benefit plan securities
Filed: 2026-05-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-07
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-07
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-05-06
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-28
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-23
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-22
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-02-05
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-05
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-01-27
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-11-25
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ARROWHEAD PHARMACEUTICALS, INC. |
| Ticker | ARWR |
| Exchange | -- |
| Sector | Services |
| Industry | Engineering, Accounting & Management Services |
| Headquarters | PASADENA, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 10.07B |
| Revenue | 1.09B |
| Net Income | 202.26M |
| P/E Ratio | 48.04 |
| EPS | 1.53 |
| Net Margin | 18.5% |
| ROE | 35.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...